Skip to main content
Log in

Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas.

Methods: To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR.

Results: We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a noveltrk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the α form restricted to a subgroup of high-grade and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas.

Conclusions: When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR. p53 Gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.Cancer Res 1991;51:6393–96.

    CAS  PubMed  Google Scholar 

  2. Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK. Mechanisms of p53 loss in human sarcomas.Proc Natl Acad Sci USA 1990;87:5863–7.

    CAS  PubMed  Google Scholar 

  3. Cance WG, Brennan MF, Dudas ME, Huang C-M, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas.N Engl J Med 1990;323:1457–62.

    CAS  PubMed  Google Scholar 

  4. Mandahl N, Heim S, Johansson B, et al. Lipomas have characteristic chromosomal rearrangements of 12q13–q14.Int J Cancer 1987;39:685–8.

    CAS  PubMed  Google Scholar 

  5. Meltzer PM, Jankowski SA, Dal Cin P, Sandberg AA, Paz IB, Coccia MA. Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors.Cell Growth Diff 1991;2:495–501.

    CAS  PubMed  Google Scholar 

  6. Slamon DJ, Clark GM, Wong SJ, Levin LJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER/neu oncogene.Science 1987;235:177–82.

    CAS  PubMed  Google Scholar 

  7. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of theret proto-oncogene and is frequently detected in human thyroid papillary carcinomas.Cell 1990;60:557–63.

    Article  CAS  PubMed  Google Scholar 

  8. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.Science 1988;241:42–52.

    CAS  PubMed  Google Scholar 

  9. Hunter T. Cooperation between oncogenes.Cell 1991;69:249–70.

    Google Scholar 

  10. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity.Cell 1990;61:203–12.

    Article  CAS  PubMed  Google Scholar 

  11. Aaronson SA. Growth factors and cancer.Science 1991;254:1146–53.

    CAS  PubMed  Google Scholar 

  12. Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction.Cell 1991;64:281–302.

    Article  CAS  PubMed  Google Scholar 

  13. Sporn MB, Roberts AB. Autocrine growth factors and cancer.Nature 1985;313:745–7.

    Article  CAS  PubMed  Google Scholar 

  14. Wilks AF. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.Proc Natl Acad Sci USA 1989;86:1603–7.

    CAS  PubMed  Google Scholar 

  15. Lai C, Lempke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system.Neuron 1991;6:691–704.

    Article  CAS  PubMed  Google Scholar 

  16. Sambrook J, Fritsch EF, Maniatis T.Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:7.39–7.52.

    Google Scholar 

  17. Jansen R, Ledley FD. Production of discrete high specific activity DNA probes using the polymerase chain reaction.Gene Anal Tech 1989;6:79–83.

    Article  CAS  PubMed  Google Scholar 

  18. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors.Proc Natl Acad Sci USA 1977;74:5463–7.

    CAS  PubMed  Google Scholar 

  19. Devereux J, Haberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX.Nucl Acid Res 1984;12:387–95.

    CAS  Google Scholar 

  20. Cance WG, Craven RJ, Liu ET. Expression polymerase chain reaction: a sensitive method for analysis of genes in human tumors.Surg Oncol 1992;1:309–14.

    Article  CAS  PubMed  Google Scholar 

  21. Katoh M, Hattori Y, Sasaki H, et al. K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase.Proc Natl Acad Sci USA 1992;89:2960–4.

    CAS  PubMed  Google Scholar 

  22. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase.Oncogene 1991;6:1677–83.

    CAS  PubMed  Google Scholar 

  23. DeVries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. Thefms-like tyrosine kinase, a receptor for vascular endothelial growth factor.Science 1992;55:989–91.

    Google Scholar 

  24. O'Bryan JP, Frye RA, Cogswell PC, et al.axl, a transforming gene isolated from primary leukemia cells, encodes a novel receptor tyrosine kinase.Mol Cell Biol 1991;11:5016–31.

    PubMed  Google Scholar 

  25. Cance WG, Craven RJ, Weiner TM, Liu ET. Novel protein kinases expressed in human breast cancer.Int J Cancer 1993;54:571–7.

    CAS  PubMed  Google Scholar 

  26. Partanen J, Armstrong E, Makela TP, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.Mol Cell Biol 1992;12:1698–707.

    CAS  PubMed  Google Scholar 

  27. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK, a structurally distinctive protein tyrosine kinase associated with focal adhesions.Proc Natl Acad Sci USA 1992;89:5192–6.

    CAS  PubMed  Google Scholar 

  28. Leveen P, Claesson-Welsh L, Heldin C-H, Westermark B, Betsholtz C. Expression of messenger RNAs for platelet-derived growth factor and its receptors in human sarcomas cell lines.Int J Cancer 1990;46:1066–70.

    CAS  PubMed  Google Scholar 

  29. Palman C, Bowen-Pope DF, Brooks JJ. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.Lab Invest 1992;66:108–15.

    CAS  PubMed  Google Scholar 

  30. Franklin WA, Christison WH, Colley M, Montag AG, Stephens JK, Hart CE.In situ distribution of the b-subunit of platelet-derived growth factor receptor in non-neoplastic tissue and in soft tissue tumors.Cancer Res 1990;50:6344–8.

    CAS  PubMed  Google Scholar 

  31. Perosio PM, Brooks JJ. Expression of growth factors and growth factor receptors in soft tissue tumors: implications for the autocrine hypothesis.Lab Invest 1989;60:245–53.

    CAS  PubMed  Google Scholar 

  32. Nister M, Claesson-Welsh L, Eriksson A, Heldin C-H, Westermark B. Differential expression of platelet-derived growth factor receptor in human glioma cell lines.J Biochem 1991;266:16755–763.

    CAS  Google Scholar 

  33. Kumabe T, Sohona Y, Kayama T, Yoshimoto T, Yamamoto T. Amplification of a platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary tumor of glial origin.Oncogene 1992;7:627–33.

    CAS  PubMed  Google Scholar 

  34. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggest the presence of autocrine and paracrine loops.Cancer Res 1992;52:3213–9.

    CAS  PubMed  Google Scholar 

  35. Westermark B, Heldin C-H. Platelet-derived growth factor in autocrine transformation.Cancer Res 1991;51:5087–92.

    CAS  PubMed  Google Scholar 

  36. Fleming TP, Matsui T, Heidaran MA, Molloy CJ, Artrip J, Aaronson SA. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.Oncogene 1992;7:1355–9.

    CAS  PubMed  Google Scholar 

  37. Smits A, Funa K, Vassbotn FS, et al. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin.Am J Pathol 1992;140:639–48.

    CAS  PubMed  Google Scholar 

  38. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins.Proc Natl Acad Sci USA 1991;88:8392–6.

    CAS  PubMed  Google Scholar 

  39. Guan J-L, Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation.Nature 1992;358:690–2.

    Article  CAS  PubMed  Google Scholar 

  40. Martin-Zanca D, Hughes SH, Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.Nature 1986;319:743–8.

    Article  CAS  PubMed  Google Scholar 

  41. Slamon DJ, deKerion JB, Verma IM, Cline MJ. Expression of cellular oncogenes in human malignancies.Science 1984;224:256–64.

    CAS  PubMed  Google Scholar 

  42. Israel MA, Helman LJ, Miser J. Patterns of proto-oncogene expression: a novel approach to the development of tumor markers. In: DeVita VT, Hellman S, Rosenberg SA, eds.Important advances in oncology. New York: JB Lippincott, 1987:87–104.

    Google Scholar 

  43. Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system.J Clin Invest 1987;86:804–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiner, T.M., Liu, E.T., Craven, R.J. et al. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Annals of Surgical Oncology 1, 18–27 (1994). https://doi.org/10.1007/BF02303537

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303537

Key Words

Navigation